A new report published in Brain Medicine reveals that a single dose of the drug Osanetant, administered shortly after a traumatic event, significantly dampens fear expression in female mice. The findings provide strong preclinical support for using Nk3R antagonism as a sex-specific, time-sensitive intervention to reduce the risk of posttraumatic stress disorder (PTSD).
from Medical Xpress - latest medical and health news stories https://ift.tt/9KQoGvu
